[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349045-105":59,"doc-detail-349045-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeting-tumor-dormancy-the-next-frontier-in-gastrointestinal-stromal-tumor-therapy-review-article","Targeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy - Review article","","Gastrointestinal stromal tumors (GISTs), the most common mesenchymal neoplasms of the digestive tract, are driven by KIT/PDGFRA mutations, and tyrosine kinase inhibitors such as imatinib represent a paradigm of precision oncology. Yet acquired imatinib resistance remains a major determinant of poor prognosis. This review links tumor dormancy and cancer stem cell (CSC) persistence states with therapy resistance, recurrence, and metastasis. It compiles evidence that non-genetic dormant programs and KITlow stem-like/CSC-like subpopulations also occur in GIST, shaping new therapeutic frontiers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-tumor-dormancy-the-next-frontier-in-gastrointestinal-stromal-tumor-therapy-review-article/349045/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-tumor-dormancy-the-next-frontier-in-gastrointestinal-stromal-tumor-therapy-review-article/349045.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What drives most gastrointestinal stromal tumors?","Question",{"text":113,"@type":114},"Most GISTs are primarily driven by mutations in KIT/PDGFRA.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is imatinib not sufficient for long-term control of GIST?",{"text":118,"@type":114},"Acquired resistance to imatinib remains a major cause of poor prognosis in GIST patients.",{"name":120,"@type":111,"acceptedAnswer":121},"How are tumor dormancy and cancer stem cell states connected to treatment failure?",{"text":122,"@type":114},"Dormancy and CSC models are linked to therapy resistance, tumor recurrence, and metastasis, and GIST shows analogous persistence states including dormant cells and KITlow stem-like/CSC-like subpopulations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349045,1790501832,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Neoplasia 76 (2026) 101306  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \nReview article  \nTargeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy  \nSihan Wu a,1, Hao Liu a,1, Yuhan Yina, Jiehan Lia, Zhen Zhang b, Wei Lic,*, Yang Fu a,*   \na Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China  \nb Department of Abdominal and Pelvic Tumor Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China c Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China  \nA R T I C L E I N F O  \nKeywords:  \nGastrointestinal stromal tumor Tumor dormancy  \nDrug resistance  \nCancer stem cell  \nA B S T R A C T  \nGastrointestinal stromal tumors (GISTs), the most common mesenchymal neoplasms of the digestive tract, are primarily driven by mutations in KIT/PDGFRA. The remarkable success of tyrosine kinase inhibitors such asimatinib (IM) in treating GIST has established them as a paradigm of precision medicine in modern oncology. However, acquired resistance to IM remains a major cause of poor prognosis in GIST patients. Exploring novel mechanisms of IM resistance is critically important for improving outcomes. Tumor dormancy and cancer stem cell (CSC) models, observed across multiple malignancies, are closely linked to therapy resistance, tumor recurrence, and metastasis. Emerging evidence suggests that analogous non-genetic persistence states also exist in GIST, including dormant cells and KITlow stem-like/CSC-like subpopulations. This review summarizes the  \nAbbreviations: 2-DG, 2-deoxy-D-glucose; AML, acute myeloid leukemia; ATG7, autophagy-related gene 7; ATRA, all-trans retinoic acid; AXL, AXL receptor tyrosine kinase; BCL6, B-cell lymphoma 6; BMI1, BMI1 proto-oncogene, polycomb ring finger; B-MYB, MYBL2 (MYB proto-oncogene like 2); CAFs, cancer-associated fibroblasts; CAR-T, chimeric antigen receptor T-cell; CCNA2, cyclin A2; CDC25A, cell division cycle 25A; CD133, prominin-1; CD34, CD34 molecule; CD44, CD44 molecule; CDH1, cadherin 1; CDKI, cyclin-dependent kinase inhibitor; CML, chronic myeloid leukemia; COX I, cytochrome c oxidase subunit I; COL17A1, collagen type XVII alpha 1 chain; CSC, cancer stem cell; CXCL1, C-X-C motif chemokine ligand 1; CXCL9, C-X-C motif chemokine ligand 9; CXCL10, C-X-C motif chemokine ligand 10; DDR1, discoidin domain receptor 1; DDR2, discoidin domain receptor 2; DEC2, differentiated embryo chondrocyte expressed 2; DREAM complex, DP, RBlike, E2F and MuvB complex; DTC, disseminated tumor cell; DYRK1A, dual specificity tyrosine phosphorylation regulated kinase 1A; E2F4, E2F transcription factor 4; E2F5, E2F transcription factor 5; EC, endothelial cell; ECM, extracellular matrix; EETs, epoxyeicosatrienoic acids; EpCAM, epithelial cell adhesion molecule; ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase; Fbxw7, F-box and WD repeat domain containing 7; FcγRIIA, Fc gamma receptor IIA; FOXM1, forkhead box M1; Gas6, growth arrest-specific 6; G-CSF, granulocyte colony-stimulating factor; GDNF, glial cell line-derived neurotrophic factor; GFRA1, GDNF family receptor alpha 1; GIST, gastrointestinal stromal tumor; HER2, human epidermal growth factor receptor 2; HGF, hepatocyte growth factor; ICC, interstitial cells of Cajal; IFN-γ, interferon gamma; IgG, immunoglobulin G; IM, imatinib; IL-10, interleukin 10; KIT, KIT proto-oncogene, receptor tyrosine kinase; LC3-II, microtubule-associated protein 1 light chain 3-II; LGR5, leucine-rich repeat-containing G-protein coupled receptor 5; LICs, leukemia-initiating cells; LIN37, lin-37 DREAM MuvB core complex component; LIN52, lin-52 DREAM MuvB core complex component; MAPK, mitogen-activated protein kinase; MCOLN1, mucolipin 1; Nanog, Nano","cbCaiiz0TJPe4TK1","https://ap.wps.com/l/cbCaiiz0TJPe4TK1","pdf",5872951,17,"English","# Abstract","[{\"question\":\"What drives most gastrointestinal stromal tumors?\",\"answer\":\"Most GISTs are primarily driven by mutations in KIT/PDGFRA.\"},{\"question\":\"Why is imatinib not sufficient for long-term control of GIST?\",\"answer\":\"Acquired resistance to imatinib remains a major cause of poor prognosis in GIST patients.\"},{\"question\":\"How are tumor dormancy and cancer stem cell states connected to treatment failure?\",\"answer\":\"Dormancy and CSC models are linked to therapy resistance, tumor recurrence, and metastasis, and GIST shows analogous persistence states including dormant cells and KITlow stem-like/CSC-like subpopulations.\"}]","Targeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy - Review article | PDF",1790081362,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b670a75dc80410eb29dca999da598ccd.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0df442dde0f2c995e13b445771378970.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8e537827be18fb7ee176bcd09390c3a.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d944be626b76421eab6245c06a1aca39.webp",980,1306]